Skip to main content
. 1998 Nov;114(2):179–188. doi: 10.1046/j.1365-2249.1998.00711.x

Fig. 4.

Fig. 4

Representative cytofluorimetric patterns of variation in FasL expression after IL-6 treatment of myeloma cell clones (MCC) (right panels). IL-6-insensitive MCC-2 and -7 were not affected by IL-6 incubation, in contrast to the IL-6-sensitive MCC-4 and -6, which showed a variable down-modulation of their FasL cellular expression.